Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

Relmada Therapeutics Inc. (RLMD) — CORAL GABLES, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced plans to host a conference call and webcast on Thursday, November 12, 2026 at 4:30 PM ET to discuss financial results for the third quarter ended September 30, 2026, and recent business progress. Conference Call and Webcast Information: D

Source: GlobeNewswire — read the full announcement there.

See our Relmada Therapeutics company profile for background, links, and more Relmada Therapeutics news.